Paclitaxel induces lymphatic endothelial cells autophagy to promote metastasis.
Ontology highlight
ABSTRACT: Cytotoxic therapy for breast cancer inhibits the growth of primary tumors, but promotes metastasis to the sentinel lymph nodes through the lymphatic system. However, the effect of first-line chemotherapy on the lymphatic endothelium has been poorly investigated. In this study, we determined that paclitaxel, the anti-cancer drug approved for the treatment of metastatic or locally advanced breast cancer, induces lymphatic endothelial cell (LEC) autophagy to increase metastases. While paclitaxel treatment was largely efficacious in inhibiting LEC adhesion, it had no effect on cell survival. Paclitaxel inhibited LEC migration and branch point formation by inducing an autophagy mechanism independent of Akt phosphorylation. In vivo, paclitaxel mediated a higher permeability of lymphatic endothel
SUBMITTER: Zamora A
PROVIDER: S-EPMC6925245 | biostudies-literature | 2019 Dec
REPOSITORIES: biostudies-literature
ACCESS DATA